$0.26
+0.01 (+5.35%)
Open$0.24
Previous Close$0.25
Day High$0.28
Day Low$0.24
52W High$0.88
52W Low$0.32
Volume—
Avg Volume6.60M
Market Cap127.90M
P/E Ratio—
EPS$-0.44
SectorBiotechnology
Analyst Ratings
Buy
11 analysts
Price Target
+7,700.8% upside
Current
$0.26
$0.26
Target
$20.29
$20.29
$11.90
$20.29 avg
$29.33
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 114.23M | 141.86M | 23.70M |
| Net Income | -193,538,968 | -216,325,225 | -3,056,252 |
| Profit Margin | -169.5% | -161.0% | -12.9% |
| EBITDA | -195,332,472 | -230,459,324 | -4,785,189 |
| Free Cash Flow | — | — | -2,136,953 |
| Rev Growth | -19.5% | -19.5% | +16.7% |
| Debt/Equity | — | — | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |